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INTRODUCTION
Atrial fibrillation (AF) is a complex arrhythmia assumed
to result from multiple reentry circuits, which in some ins-
tances might be several decades old. The ‘‘Cox’’ Maze proce-
dure has become the standard AF surgery (1-5). Numerous
modifications to the original Maze procedure have since been
described, reporting high sinus conversion rates (6-19). The
concepts regarding the mechanism of AF have further evolved
with studies indicating that intermittent AF originates from
ectopic focuses in the pulmonary veins. Catheter ablation
techniques or surgery involving isolation of mainly the pul-
monary veins have been founded on these concepts (17-20).
Because fibrillation surgery is an additional procedure to the
main cardiac procedure, cardiopulmonary bypass and cross
clamp times might be prolonged. Therefore, it is important
that the selected energy source not only be capable of produc-
ing complete transmural lesion but also achieve it in the short-
est time possible. Recently, radiofrequency and microwave
energies have been extensively studied to investigate their
suitability as alternative energy sources to cryothermia (21-
30). An energy source that can be applied epicardially on the
beating heart has the potential to not only minimize endo-
cardial trauma but also to significantly reduce the aortic cross
clamping time that would otherwise be necessary with conven-
tional techniques (8, 28-31). Microwave is one such energy
source that fits this description and as such it is currently being
used to perform epicardial ablative surgery, either in the on-
or off-pump state on patients undergoing cardiac surgery.
Specifically it has been found to be useful in patients with
AF undergoing off-pump beating-heart coronary artery bypass
grafting (OPCAB) or in patients with lone AF, which previ-
ously would have otherwise been considered an over-invasive
treatment option. Although some reports, despite these advan-
tages, might point to a possibly lower success rate with epi-
cardial ablation when comparing it to conventional endocar-
dial cryothermia (9, 24, 25, 29), it has been well demonstrated
that complete linear transmural thermal lesions can be cre-
ated with either microwave or radiofrequency ablation pro-
vided proper techniques are employed (30). 
The purpose of the present study was to compare the results
of AF surgery with epicardial microwave ablation combined
with or without routine valvular surgery and the cryosurgi-
cal Maze operation. 
MATERIALS AND METHODS
Between July 1997 and June 2003, 280 patients received
the Maze procedure using cyrothermia (Cryo group, Frig-
itronics Cardiac Cryosurgical System 200; Frigitronics, Inc,
Coopersurgical, Shelton, CT, U.S.A.) with or without con-
comitant mitral procedures. Since July 2003, 14 patients
underwent epicardial microwave maze (Epi-MW group) using
the Flex 4 microwave antenna (Afx Inc, Fremont, CA, U.S.A.).
The selected 28 hospital survivors who were the subjects of
the present study were divided into 14 matched pairs. The
patients were matched for age, sex, duration of AF, cardio-
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Epicardial Microwave Application in Chronic Atrial Fibrillation Surgery
The search for alternative epicardial energy sources in the treatment of nonvalvular
atrial fibrillation (AF) is a relatively new aspect of the evolving spectrum of Maze oper-
ations. We tested the hypothesis that epicardial microwave ablation produces iden-
tical results to those of the standard cryosurgical Maze. Fourteen consecutive patients
with chronic AF underwent on-pump epicardial Maze procedures after routine car-
diac surgery. The results were compared with those of 14 control patients selected
from our Maze database of 280 patients. There were no differences in age, sex, car-
diothoracic ratio, duration of AF, pump time, intensive care unit or hospital stays.
The aortic cross clamp time with epicardial microwave was, however, shortened
from 110 to 65 minutes (p=0.011). The recurrence rate of AF after discharge showed
no significant difference between the two groups (14% vs. 15%, p=0.841). Epicar-
dial microwave ablation might be a valuable alternative to the conventional cryosur-
gical Maze procedure, especially for those patients without associated mitral valve
disease.
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thoracic ratio, preoperative left atrial dimension, incidence
of fine AF, and concomitant cardiac conditions (Table 1, 2).
To prevent selection bias, the patients were matched only by
the preoperative variables, not taking into consideration the
postoperative results.
The procedures, which were followed by transesophageal
echocardiography, were performed by a single surgeon. Sub-
sequent echocardiographic data were collected at 1 week, 3
and 6 months, and 1 yr after surgery.
Standard anesthetic and monitoring techniques
Surgical ablation was performed under total cardiopulmo-
nary bypass with aortobicaval cannulation followed by open-
ing of the left atrial and vena caval pericardial reflection. Micro-
wave energy was applied with FLEX 4 microwave ablation
probes (Afx Inc, Fremont, CA, U.S.A.). The energy level used
was 65 watts with the duration of ablation of 90 sec for epi-
cardial ablation in the beating-heart condition and 45 sec
for endocardial and epicardial ablation in the arrested-heart
state. With epicardial ablation in patients undergoing non-
open-heart cardiac surgery, the left and right pulmonary veins
were separately isolated and connected to each other with a
connecting lesion. The left atrial appendage was amputated
or stapled off, after which another ablation line was created
epicardially to connect to the pulmonary venous ablation
lines. Pulmonary venous epicardial pacing was performed
within the area of the isolated pulmonary veins to confirm elec-
trical conduction block. A right atrial ablation line was formed
by creating a thermal lesion extending from the superior vena
cava to the inferior vena cava (crista terminalis). In those patients
undergoing AF surgery concomitant to open heart surgery,
cardiopulmonary bypass was performed after double venous
cannulation. AF surgery was initiated with a long right atrial
incision from the tip of the right atrial appendage to the fossa
ovalis. The right atrial isthmus and the line from the atrial
incision to the tricuspid valve were then ablated. The left
atrial procedure was initiated with a standard left atriotomy
incision along the Waterston groove, and extended toward the
left inferior pulmonary vein, constituting the superior con-
necting lesion between the two pulmonary veins. The lines
toward the mitral annulus (left atrial isthmus) and coronary
sinus were then ablated either endocardially or epicardially.
A temporary epicardial pacing wire was placed at the transi-
tional junction of the superior vena cava and the right atrium
or at the left atrial roof. The second pacing wire was placed
at the right atrial appendage close to the interventricular sep-
tum. The pacing wires were used to evaluate the atrial p-wave
activity for the presence of conduction block as well as for
detecting the appearance or onset of the p-wave in the post-
operative period. The atrial pacing wires were also used to
induce atrial fibrillation by rapid atrial pacing.
Postoperative management
Amiodarone was used to treat supraventricular premature
beats as well as to treat either recurrent AF or flutter. A loading
atrial intravenous dose of 300 mg was initially administered
followed by a continuous infusion of 900 mg every 24 hr.
Maintenance amiodarone of 200-400 mg was administered
orally every 12 hr until discharge. Although a small routine
dose of diuretics was sometimes necessary to maintain fluid
balance, with preservation of the right atrial appendage in
the latter part of the series, frank pulmonary edema was no
longer detected. Warfarin was used routinely except in epi-
cardial off-pump beating heart Maze procedures in which
left atrial incision was not performed.
Statistical analysis
The focus of this study was to provide observational data
on a new or modified method of performing the Maze pro-
*, independent t-test; 
� , Fisher’s exact test.
AF, atrial fibrillation; CTR, cardiothoracic ratio; CPB, cardiopulmonary
bypass time; Epi-MW, microwave epicardial ablation; Cryo, cryoabla-
tion; LAD, Left atrial dimension.
Groups Epi-MW Cryo p value
Age (yr) 52.4±11.7 50.3±8.9 0.59*
Sex (M/F) 14 (8/6) 14 (10/4) 0.69
�
AF duration (yr)  3.7±3.6 (10-1) 4.8±7.7 (30-1) 0.76*
CTR* (%)  57.9±6.6 (73-47)  54.8±5.7 (69-47) 0.22*
LAD (mm) 55.1±151.2 (88-38) 53.1±76.9 (69-39) 0.31*
Fine AF (n) 7 8 0.36
�
Table 1. Patient’s demographics
*, independent t-test.
ACC, aortic cross clamp time; Epi-MW, microwave epicardial ablation;
CABG, coronary artery bypass graft; Cryo, cryoablation; OPCAB, off-
pump coronary artery bypass; MVP, mitral valvuloplasty; PDA, patent
ductus arteriosus; MVR, mitral valve replacement; AVR, Aortic valve
replacement; TVP, tricuspid valvuloplasty; VSD, ventricular septal defect;
ASD, atrial septal defect; Beating CAB, On pump beating heart CABG;
AAR, ascending aorta replacement.
Epi-MV Cryo p value*
CPB (min) 154.2±68.7 158.5±52.9 0.46
ACC (min) 65±49 110.4±38.3 0.01
Conventional CABG 1 3
OPCAB 2
MVP+Beating CAB 1
MVP 7 6
MVP+PDA 1
MVR 2 1
MVR+AVR 1
AVR+AAR 1
TVP 1
VSD 1
ASD 1
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cedure involving epicardial microwave ablation and to assess
the performance of the new surgical device. Continuous vari-
ables were expressed as means±standard deviation. The means
were compared using the independent t-test and ANOVA.
Differences of frequency were compared using Fisher’s exact
test and chi-square test. A p value less than 0.05 was con-
sidered statistically significant. The statistical analysis was
performed using the SPSS 10.0 software package (SPSS Inc.,
Chicago, IL, U.S.A.).
RESULTS
There were no differences in age, sex, cardiothoracic ratio,
left atrial dimension, and duration of AF. Cardiopulmonary
bypass time, intensive care unit and hospital stays also showed
no differences. Aortic cross clamp time was significantly less
with microwave ablation (p=0.011, ANOVA) (Table 1, 3).
Concomitant surgical procedures included coronary bypass
in 7 patients (4 Epi-MW, 3 Cryo), valvular surgery in 21 (11
Epi-MW, 10 Cryo) and congenital heart surgery in 2 patients
(1 Epi-MW, 1 Cryo) (Table 2). There was no mortality, stroke,
myocardial infarction, or re-exploration for bleeding. No per-
manent pacemaker implantation was necessary in any case. 
Sinus conversion occurred in 25 of 28 patients in the first
month (12 Epi-MW, 13 Cryo), and in 26 of 28 patients (13
Epi-MW, 13 Cryo) by 6 months postoperatively. The con-
duction block between the pulmonary veins and the non-iso-
lated left atrium was verified by intraoperative pulmonary
vein epicardial pacing (Table 4). Recurrent AF occurred in 2
patients (1 Epi-MW, 1 Cryo) and in 14 and 15% of the pati-
ents after discharge (p=0.841, chi-square test) (Table 5). The
aortic clamp time was significantly shortened with Epi-MW
maze procedure compared to the Cryo maze procedure (p=
0.011).
DISCUSSION
The conventional Maze procedure, though effective, is asso-
ciated with certain limitations such as poor left atrial func-
tional recovery and loss of effective atrial contraction. Several
modifications were developed to overcome these shortcom-
ings, and some of them showed good results for atrial func-
tional recovery (4, 10-12, 31, 32). The evolution and appli-
cation of more advanced concepts such as posterior atrial wall
reduction combined with cryoablation were thought to be
contributory (31, 32). Meanwhile, the introduction of new
devices using alternative energy sources added benefits, which
included simplification and reduction of the operative time
without compromising the surgical outcome. Currently, radio-
frequency and microwave devices have shown the most promise
among the energy sources that have been looked into as poten-
tially suitable alternatives to cryoablation as they are easy to
use, less time consuming and conducive to good results (21-
30). However, some have pointed out that epicardial lesions
created with either radiofrequency or cryoablation might be
less penetrative than endocardial lesions due to the cooling
effect of circulating blood and the epicardial fat tissue that
can block energy transfer, necessitating a longer duration of
ablation. Still, the time consumed is much less than it would
take with the cut and sew technique (21, 28). Positive studies
using microwave by a completely epicardial approach have
shown success rates similar to those achieved with cryoabla-
tion (21, 22, 32). Although the endocardial approach is the-
oretically more effective, the disadvantages of this approach
can include the necessitation of cross clamping and the inabil-
ity to allow electrophysiological conduction block confirma-
tion prior to aortic cross-clamp release and to CPB weaning.
Compared to some of the other energy sources, the advantages
of microwave energy include the ability to create complete
transmural lesions, highly localized tissue destruction, immu-
*, independent t-test.
Epi-MW, microwave epicardial ablation; Cryo, cryoablation; ICU, inten-
sive care unit; LOS, length of stay; MI, myocardial infarction.
Epi-MW Groups Cryo p value*
No. 14 14
ICU stay (days)  3.1±1.9 (1-7) 2.5±1.3 (1-6) 0.38
LOS (days)  15.1±12.3 (6-55) 12.1±6.0 (6-24) 0.28
Mortality 0 0
Stroke 0 0
MI 0 0
Re-exploration 0 0
for bleeding
Pacemaker implant 0 0
Table 3. Early hospital outcomes
Epi-MW Groups Cryo
No. 14 14
One month later
Sinus rhythm (%) 12 (85.7) 13 (92.9) 
Atrial fibrillation (%) 1 (7.1) 1 (7.1)
Atrial flutter (%)  1 (7.1) 0
Amiodarone (%) 10 (71.4) 7 (50.0)
6 months later
Sinus rhythm (%) 13 (92.9) 13 (92.9) 
Atrial fibrillation (%) 1 (7.1) 1 (7.1)
Amiodarone (%) 2 (14.3) 1 (7.1)
Table 4. Postoperative rhythm during the follow-up
Epi-MW, microwave epicardial ablation; Cryo, cryoablation.
Epi-MW Cryo p value*
Treatment failure 1/14 (7.1%) 1/14 (7.1%) 1.0
Events/follow-up 7/50 (14%) 8/53 (15%) 0.84
Table 5. Recurrence of AF during the follow-up
*, Fisher’s exact test.
Epi-MW, microwave epicardial ablation; Cryo, cryoablation.nity to the detrimental effects of fat tissue on energy transfer,
ease of creating linear lesions facilitating isolation of the pul-
monary veins, and the ability to achieve complete ablation
epicardially (30). Of note, the energy release is unidirection-
al, preventing collateral damage. This is particular impor-
tance to epicardial beating-heart ablation as ablation could
be carried out from the dorsal part of the heart without fur-
ther protective measures. Review of our own series has also
shown good results with AF ablation using the epicardial
beating-heart approach. It was especially useful in situations
where the ablation was incomplete, as further ablation was
possible with a still-beating heart. The traditional Maze oper-
ation, however, would require the re-institution of cardiopul-
monary bypass and aortic cross-clamping. In view of the increas-
ing population of elderly patients with AF and the ensuing
complications, it appears that a large group of patients that
otherwise would not have had the benefit of receiving AF
surgery can receive this surgery, because AF surgery with
this technology might now be viewed by surgeons as being
less invasive and much simplified. Likewise, the epicardial
Maze procedure can not only benefit patients undergoing
beating-heart coronary artery bypass grafting but also patients
undergoing valve surgery. However, it is important to con-
sider that the Maze procedure can prolong cardiopulmonary
bypass time, though the procedure with the epicardial approach
is simplified. Consequently, in finally weighing the benefit
in valve surgery patients, the disadvantages of the additional
obligatory prolongation in the CPB time and the aortic cross-
clamp time should be considered. 
In this study, no microscopic or macroscopic examinations
were performed on the thermal lesions. We cannot speculate
on the effects of the ablation duration on either the lesion size
or depth and the effects of the tissue thickness. Accurate deter-
mination of the influence of these factors would require sup-
plementary animal studies. A further limitation is the small
size of the study population which may not be enough to
obtain sufficient confidence.
In conclusion, the results of the current study showed epi-
cardial microwave ablation with subsequent other cardiac
procedure to be equally effective in inducing recovery of sinus
rhythm in those who have undergone a conventional Maze
procedure by open-heart surgery. Furthermore, it was possible
to perform the ablation in a less traumatic manner and in a
shorter time without adding to the ischemic time. In the long
term, we expect that a significant proportion of patients under-
going heart surgery with AF that would otherwise not have
received AF surgery will receive ablative AF surgery with
this new technology. 
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